Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: A multicenter southern Californian registry

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 2, 2010, Pages 272-278

  Lee, Michael S ^a   Hu, Patrick P ^b   Aragon, Joseph ^c   Shah, Atman ^d   Bhatia, Ravi ^a   Jones, Nathaniel ^c   Penny, William ^e   French, William ^f   Tobis, Jonathan ^a   Mahmud, Ehtisham ^b  

^a UCLA MEDICAL CENTER   (United States)

^b UCSD MEDICAL CENTER   (United States)

^c SANTA BARBARA COTTAGE HOSPITAL   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Drug eluting stent; Renal insufficiency; Saphenous vein graft

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

ADULT; AGING; ANGIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HIGH RISK POPULATION; HUMAN; KIDNEY FUNCTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; REGISTER; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SAPHENOUS VEIN GRAFT; STATISTICAL SIGNIFICANCE; STENT THROMBOSIS;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CALIFORNIA; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CREATININE; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955131045     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22479     Document Type: Article

References (30)

1. Fitzgibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: Long-term angiographic study. J Am Coll Cardiol 1991;17:1075-1080.
2. Fitzgibbon GM, Kafka HP, Leach AJ, Keon KW, Hooper GD, Burton JR. Coronary artery bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626. (Pubitemid 26288642)
3. de Feyter PJ. Percutaneous treatment of saphenous vein bypass graft obstructions: A continuing obstinate problem. Circulation 2003;107:2284-2286.
4. Baim DS. Percutaneous treatment of saphenous vein graft disease. J Am Coll Cardiol 2003;42:1370-1372.
5. Guthaner DF, Robert EW, Alderman EL, Wexler L. Long-term serial angiographic studies after coronary artery bypass surgery. Circulation 1979;60:250-259. (Pubitemid 9229212)
6. Bourassa MG, Engalbert M, Campeau L, Lesperance J. Progression of atherosclerosis in coronary arteries and bypass grafts: Ten years later. Am J Cardiol 1984;53:102C-107C. (Pubitemid 14075399)
7. Virmani R, Atkinson JB, Forman MB. Aorto-coronary saphenous vein bypass grafts. Cardiovasc Clin 1988;18:41-59.
8. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001;38:659-665.
9. Lefkovits J, Holmes DR, Califf RM, et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary angioplasty versus excisional atherectomy trial. Circulation 1995;92:734-740.
10. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400-2405.
11. Savage MP, Douglas JS Jr, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997;337:740-747.
12. Ellis SG, Brener SJ, DeLuca S, et al. Late myocardial ischemic events after saphenous vein graft intervention-importance of initially "nonsignificant" vein graft lesions. Am J Cardiol 1997;79:1460-1464.
13. Laham RJ, Carrozza JP, Berger C, Cohen DJ, Kuntz RE, Baim DS. Long-term (4-6 year) outcome after Palmaz-Schatz stenting-paucity of late stent-related problems. J Am Coll Cardiol 1996;28:820-826. (Pubitemid 26348142)
14. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003;92:209-214.
15. Hemmelgarn B, Southern D, Culleton B, Mitchell L, Knudtson M, Ghali W. Survival after coronary revascularization among patients with kidney disease. Circulation 2004;110: 1890-1895. (Pubitemid 39331897)
16. Kuchulakanti P, Torguson R, Chu W, et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2006;97:792-797. (Pubitemid 43313248)
17. Bonello L, DeLabriolle A, Roy P, et al. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol 2008;102:535-540.
18. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
19. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. (Pubitemid 37186209)
20. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231. (Pubitemid 38067635)
21. Lemos PA, Arampatzis CA, Hoye A, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005;95:167-172. (Pubitemid 40092079)
22. Weintraub WS, Jones EL, Morris DC, King SB III, Guyton RA, Craver JM. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 1997;95:868-877. (Pubitemid 27091527)
23. Wong SC, Baim DS, Schatz RA, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter US Palmaz-Schatz Stent Experience. J Am Coll Cardiol 1995;26:704-712.
24. de Jaegere PP, van Domburg RT, Feyter PJ, et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996;28:89-96.
25. Mann JFE, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 2001;134:629-636.
26. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
27. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483. (Pubitemid 30318271)
28. Tamashiro M, Iseki K, Sunagawa O, et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 2001;38:64-69. (Pubitemid 32611760)
29. Ota T, Umeda H, Yokota S, et al. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation. Am Heart J 2009;158:92-98.
30. Wellenius GA, Mukamal KJ, Winkelmayer WC, Mittleman MA. Renal dysfunction increases the risk of saphenous vein graft occlusion: Results from the Post-CABG trial. Atherosclerosis 2007;193:414-420.